Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Research Support, Non-U.S. Gov't

Clinical Trial

Multicenter Study

Comparative Study

Randomized Controlled Trial

Case Reports

Clinical Trial, Phase I

Observational Study

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2020

2019

2018

2016

2014

2013

2012

2011

2007

2003

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Micafungin""[mesh_terms]

15 Results

Searching titles within these results

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature.

G Kofla, Markus Ruhnke

European journal of medical research 2011;16(4):159-66

Free Full Text

Abstract

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.

Roeland E Wasmann, Eline W Muilwijk, David M Burger, Paul E Verweij, Catherijne A Knibbe, Roger J Brüggemann

Clinical pharmacokinetics 2019;57(3):267-286

Free Full Text

Abstract

Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT.

A Granata, P Berger, J El-Cheikh, G Venton, R Crocchiolo, S Fürst, C Faucher, C Oudin, D Coso, R Bouabdallah, N Vey, S Duran, E Fougereau, C Chabannon, D Blaise

Bone marrow transplantation 2014;48(11):1472-7

Full Text

Abstract

Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.

Jan Buer, Peter-Michael Rath, Joerg Steinmann, Lisa Kirchhoff, Maike Olsowski, Katrin Zilmans, Silke Dittmer, Gerhard Haase, Ludwig Sedlacek, Eike Steinmann

Scientific reports 2018;7():42886

Free Full Text

Abstract

The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.

Nathan P Wiederhold, James S Lewis

Expert opinion on pharmacotherapy 2007;8(8):1155-66

Full Text

Abstract

Echinocandin antifungal drugs.

David W Denning

Lancet (London, England) 2003;362(9390):1142-51

Full Text

Abstract

Efficacy of micafungin in empirical therapy of deep mycosis in surgically ill patients.

Kohji Okamoto, Takefumi Katsuki, Toshihisa Tamura, Shuichi Kanemitsu, Noritaka Minagawa, Takayuki Torigoe, Kazunori Shibao, Aiichirou Higure, Koji Yamaguchi

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2013;18(5):621-9

Full Text

Abstract

The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.

Gloria P Heresi, Dale R Gerstmann, Michael D Reed, John N van den Anker, Jeffrey L Blumer, Laura Kovanda, James J Keirns, Donald N Buell, Gregory L Kearns

The Pediatric infectious disease journal 2007;25(12):1110-5

Full Text

Abstract

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

M A Pfaller, D J Diekema, D Andes, M C Arendrup, S D Brown, S R Lockhart, M Motyl, D S Perlin

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2011;14(3):164-76

Full Text

Abstract

A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.

Wolfgang Knitsch, Jean-Louis Vincent, Stefan Utzolino, Bruno François, Tamás Dinya, George Dimopoulos, İlhan Özgüneş, Juan Carlos Valía, Philippe Eggimann, Cristóbal León, Philippe Montravers, Stephen Phillips, Lorraine Tweddle, Andreas Karas, Malcolm Brown, Oliver A Cornely

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016;61(11):1671-8

Free Full Text

Abstract

Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.

Seong Hyun Jeong, Dae Young Kim, Jun Ho Jang, Yeung-Chul Mun, Chul Won Choi, Sung-Hyun Kim, Jin Seok Kim, Joon Seong Park

Annals of hematology 2016;95(2):337-44

Free Full Text

Abstract

Micafungin-Induced Hypoglycemia in a Patient With Type 1 Diabetes: A Case Report and Review of Literature.

Michael Morkos, Nasha K Nensey, Anila Bindal

The Journal of clinical endocrinology and metabolism 2020;104(4):981-984

Full Text

Abstract

The inhibitory effect of micafungin on biofilm formation by Pseudomonas aeruginosa.

Ghassan M Matar, Wael Bazzi, Ahmad Sabra, Lama Zahreddine, Marie Therese Khairallah, Maysa Baroud, Usamah Hadi

Biofouling 2014;29(8):909-15

Full Text

Abstract

Micafungin use in children.

Melike Emiroglu

Expert review of anti-infective therapy 2012;9(9):821-34

Full Text

Abstract

Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.

Masaki Yamaguchi, Toshiro Kurokawa, Ken Ishiyama, Go Aoki, Mikio Ueda, Sadaya Matano, Akiyoshi Takami, Hirohito Yamazaki, Aiko Sawazaki, Hiromasa Yamauchi, Takashi Yoshida, Shinji Nakao

Annals of hematology 2011;90(10):1209-17

Full Text

Abstract

Results: 1 – 15 / 15

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Micafungin""[mesh_terms]

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature.

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.

Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT.

Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.

The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.

Echinocandin antifungal drugs.

Efficacy of micafungin in empirical therapy of deep mycosis in surgically ill patients.

The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.

Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.

Micafungin-Induced Hypoglycemia in a Patient With Type 1 Diabetes: A Case Report and Review of Literature.

The inhibitory effect of micafungin on biofilm formation by Pseudomonas aeruginosa.

Micafungin use in children.

Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.

Results for
""Micafungin""[mesh_terms]